2005
DOI: 10.1016/j.rmed.2005.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to asthma controller medication regimens

Abstract: This study confirms a previous report that adherence profiles of fluticasone and salmeterol in a single inhaler are significantly better when compared to the controller regimens of fluticasone and salmeterol in separate inhalers, fluticasone and montelukast, or fluticasone alone and similar to montelukast alone.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
83
1
8

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(97 citation statements)
references
References 10 publications
4
83
1
8
Order By: Relevance
“…This has the additional advantage of not only improving adherence to ICS but also of reducing treatment burden in asthma. 9 A perceived disadvantage of prescribing LABAs/ICS combination inhalers is the lack of flexibility in ICS dosetitration. However, a pragmatic approach of simpler treatment regimens with improved ICS adherence (and associated clinical outcomes) is likely to outweigh any potential benefits of fine-tuning ICS therapy with separate inhalers when problems of non-adherence are widespread.…”
Section: Why Does Laba Monotherapy Occur?mentioning
confidence: 99%
“…This has the additional advantage of not only improving adherence to ICS but also of reducing treatment burden in asthma. 9 A perceived disadvantage of prescribing LABAs/ICS combination inhalers is the lack of flexibility in ICS dosetitration. However, a pragmatic approach of simpler treatment regimens with improved ICS adherence (and associated clinical outcomes) is likely to outweigh any potential benefits of fine-tuning ICS therapy with separate inhalers when problems of non-adherence are widespread.…”
Section: Why Does Laba Monotherapy Occur?mentioning
confidence: 99%
“…The combination of a LABA with an ICS overcomes the last of these causes. A 24-month analysis was conducted of patient adherence to prescribed medication using administrative claims data from a large managed care organization [30]. Prescription refill rates in 3503 patients were compared for salmeterol, fluticasone, the salmeterol-fluticasone combination, and montelukast.…”
Section: Additional Benefits From Combining Laba With Icsmentioning
confidence: 99%
“…Наиболее хорошо изученной, обо-снованной и традиционно применяемой стратегией всегда считалась регулярная поддерживающая терапия комбинациями ИКС/ДДБА, при использовании которой больной получает фиксированные высокие дозы ИКС [23].…”
Section: подходы к терапии икс при баunclassified
“…Низкая приверженность в этом случае вполне объяснима, т. к. больным, не имеющим каких-либо постоянных симптомов, предлагается принимать регулярную терапию. Базы данных реальной клиниче-ской практики показывают, что большинство пациентов, которым назначена регулярная терапия стабильными дозами, принимают терапию ИКС от случая к случаю, используя примерно от 2 до 4 упаковок в течение года [23,28].…”
Section: низкая приверженность регулярной терапии иксunclassified